Medpace falls despite Q1 beats; 2026 guidance ranges include consensus
Summary
Medpace (MEDP) sinks 20% after hours despite Q1 beat and 2026 revenue and in-line EPS guidance ranges. Read more here.
Description
Medpace (MEDP) sinks 20% after hours despite Q1 beat and 2026 revenue and in-line EPS guidance ranges. Read more here.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source